SCHEMBL2987181

SCHEMBL2987181

NC(=O)c1ccc(-c2ccccc2)c(Cc2ccccn2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.50
▸ SYK P43405 4/20 0.48
▸ AURKB Q96GD4 2/20 0.48
▸ INCENP Q9NQS7 1/20 0.48
▸ LMNA P02545 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ POLB P06746 1/20 0.46
▸ MKNK1 Q9BUB5 5/20 0.45
▸ CHEK2 O96017 3/20 0.45
▸ HTT P42858 1/20 0.44
▸ MKNK2 Q9HBH9 4/20 0.43
▸ ASIC3 Q9UHC3 1/20 0.43
▸ RET P07949 1/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2987185 0.85 MKNK2 (0.55) PARP10SYKAURKBINCENPLMNA
SCHEMBL28310422 0.83 PARP10 (0.52) PARP10LMNANPC1RAB9APOLB
SCHEMBL14720212 0.80 PLA2G2A (0.59) PARP10POLBMKNK1CHEK2MKNK2
SCHEMBL28853596 0.80 EGFR (0.52) SYKAURKBINCENPLMNANPC1
SCHEMBL2987888 0.80 CYP17A1 (0.56) MKNK1CHEK2MKNK2CDC7GSK3B
SCHEMBL4530801 0.78 MKNK1 (0.46) POLBMKNK1CHEK2MKNK2MAPT
SCHEMBL30556643 0.77 CHEK2 (0.44) SYKAURKBPOLBMKNK1CHEK2
SCHEMBL28188264 0.77 CHEK2 (0.44) SYKAURKBPOLBMKNK1CHEK2
SCHEMBL1568725 0.77 PARP10 (0.54) PARP10NPC1RAB9APOLBASIC3
SCHEMBL2984193 0.76 MKNK1 (0.53) NPC1RAB9AMKNK1CHEK2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7781591-B2 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC (US) 2010-08-24 — — US disclosed
US-20070287708-A1 Substituted 3-cyanopyridines as protein kinase inhibitors WYETH LLC 2007-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287708-A1 Substituted 3-cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K7 PARP10 979/4885SYK 414/4885AURKB 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback